Benjamin Farahnik, MD
Clinical & Laboratory Dermatological Immunology · Long Beach, CANPI 1699209254
Payments from drug & device makers
Across 852 payments — averaging $232.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$76K
- Botanix SB Inc$56K
- Amgen$54K
- AbbVie$3K
- Sanofi$2K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $7K from 30 others
What the payments were for
- Consulting fees$9,2305%
- Speaking & faculty fees$160,72881%
- Travel & lodging$7,5844%
- Food & beverage$20,79210%
- Education$1200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 210 | $76,013 |
| Botanix SB Inc | 57 | $55,915 |
| Amgen | 83 | $53,525 |
| AbbVie(2 entities) | 123 | $2,676 |
| Sanofi | 41 | $1,733 |
| E.r. Squibb & Sons, L.L.C. | 38 | $1,254 |
| Johnson & Johnson | 37 | $985 |
| LEO Pharma Inc. | 36 | $900 |
| Regeneron Healthcare Solutions, Inc. | 26 | $774 |
| Lilly USA, LLC | 26 | $681 |
| Pfizer | 38 | $497 |
| Novartis | 19 | $489 |
| Galderma Laboratories, L.p. | 16 | $440 |
| Incyte Corporation | 14 | $361 |
| Sun Pharmaceutical Industries Inc. | 13 | $301 |
| Arcutis Biotherapeutics, Inc. | 12 | $253 |
| Boehringer Ingelheim | 8 | $228 |
| Almirall LLC | 10 | $225 |
| Merz North America, Inc. | 4 | $177 |
| Strata Skin Sciences, Inc. | 3 | $153 |
| Dermavant Sciences, Inc. | 3 | $136 |
| Biofrontera Inc. | 5 | $109 |
| Revance Therapeutics, Inc. | 2 | $92 |
| Mayne Pharma Commercial LLC | 4 | $92 |
| Journey Medical Corporation | 5 | $84 |
| Kyowa Kirin, Inc. | 2 | $50 |
| Organon | 3 | $46 |
| Verrica Pharmaceuticals Inc. | 1 | $43 |
| Blueprint Medicines Corporation | 1 | $36 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $34 |
| Genentech USA, Inc. | 5 | $33 |
| Sandoz | 1 | $27 |
| Lifenet Health | 1 | $26 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| LNHC, Inc | 1 | $24 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical & laboratory dermatological immunology providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $61,708 |
| Clobetasol Propionate | 121 | $5,763 |
| Ketoconazole | 231 | $3,688 |
| Metronidazole | 52 | $2,325 |
| Tacrolimus | 16 | $1,188 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 11 | $1,040 |
| CiclopiroxCiclopirox Olamine | 44 | $907 |
| Fluorouracil | 12 | $729 |
| Fluocinonide | 15 | $572 |
| Clindamycin Phosphate | 20 | $498 |
| Mupirocin | 71 | $486 |
| Triamcinolone Acetonide | 77 | $465 |
| Doxycycline Hyclate | 66 | $425 |
| Minoxidil | 18 | $376 |
| Desonide | 16 | $373 |
Paid to pharmacies, not to this prescriber.
Other clinical & laboratory dermatological immunology in Long Beach
- Adrianna BrowneOrinda$6K
- Lawrence MattLos Angeles$2K
- Veena VanchinathanLos Angeles$320
- Recia BlumenkranzMenlo Park$41
- Melinda LongakerMenlo Park$24
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.